Efficacy of a Novel Cellular, Acellular, Matrix-like Product (CAMP) Plus Standard of Care Versus Standard of Care Alone in the Management of Post-Mohs Micrographic Surgery Defects.

NCT07695389 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
160
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

BioLab Holdings

Collaborators